Profile

Michael D. Chan, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

197 Ratings
16 Comments

Michael D. Chan, M.D.

Associate Professor,


Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: mchan@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., Johns Hopkins University, 1998
  • M.D., New York University School of Medicine, 2004

NPI Number

  • 1225151152
Michael D. Chan, M.D.

Doctor Rating

4.8 out of 5

197 Ratings
16 Comments

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology
Comprehensive Cancer Center
Brain Tumor Center of Excellence

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: mchan@wakehealth.edu

Recent Publications

Okada H, Butterfield LH, Hamilton RL, Hoji A, Sakaki M, Ahn BJ, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively MO, Chan MD, Salazar AM, Shaw EG, Potter DM, Lieberman FS. Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Clin Cancer Res. 2015;21(2):286-294.

Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci. 2015;22(3):561-565.

Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan M, Zhou X, Qasem S, Pochampally R, Mo YY, Watabe K. Roles of the cyclooxygenase 2-matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. J Biol Chem. 2015;290(15):9842-9854.

Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(3):536-542.

Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD. Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol. 2015;123(1):171-177.

Rapp SR, Case LD, Peiffer A, Naughton MM [sic] [Naughton MJ], Chan MD, Stieber VW, Moore DF Jr, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol. 2015;33(15):1653-1659.

Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015;():.

Chan MD. Recent technical advances and indications for radiation therapy in low-grade glioma. Semin Radiat Oncol. 2015;25(3):189-196.

Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD. Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Greene-Schloesser D, Payne V, Peiffer AM, Hsu FC, Riddle DR, Zhao W, Chan MD, Metheny-Barlow L, Robbins ME [deceased]. The peroxisomal proliferator-activated receptor (PPAR) alpha agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiat Res. 2014;181(1):33-44.

Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer. 2014;120(3):433-441.

Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Bourland JD, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. J Neurooncol. 2014;117(1):167-174.

Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotact Funct Neurosurg. 2014;92(1):53-58.

Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD. Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol. 2014;37(2):177-181.

Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T [deceased], Blevins M, High K, Lesser GJ. Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol. 2014;16(12):1639-1644.

Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014;16(9):1283-1288.

Neal MT, Chan MD, Lucas JT Jr, Loganathan A, Dillingham C, Pan E, Stewart JH IV, Bourland JD, Shaw EG, Tatter SB, Ellis TL. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg. 2014;82(6):1250-1255.

Joye RP, Williams LB, Chan MD, Witkin AJ, Schirmer CM, Mignano JE, Wazer DE, Yao KC, Wu JK, Duker JS. Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma. Ophthalmic Surg Lasers Imaging Retina. 2014;45(2):125-131.

Leyrer CM, Chan MD, Peiffer AM, Horne E, Harmon M, Carter AF, Hinson WH, Mirlohi S, Duncan SE, Dietrich AM, Lesser GJ. Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study. Pract Radiat Oncol. 2014;4(2):130-135.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2):429-435.

Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol. 2014;120(1):163-169.

Kuhn EN, Taksler GB, Dayton O, Loganathan A, Bourland D, Tatter SB, Laxton AW, Chan MD. Is there a tumor volume threshold for postradiosurgical symptoms? A single-institution analysis. Neurosurgery. 2014;75(5):536-545.

Lucas JT, DiNotto J, Dolesh W, Jung Y, Whitlow CT, Maldjian JA, Chan MD, Bourland J. Safety assessment, artifact reduction, and description of geometric distortion associated with diffusion imaging (DWI) with rigid head frame immobilization for stereotactic radiosurgery [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(1 Suppl):S903.

Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD. Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S245.

Randolph DM, Peiffer AM, Paulsson AK, Hinson W, Laxton AW, Tatter SB, Debinski W, Chan MD. Does delay of start of radiation affect clinical outcomes of glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S295.

Holmes JA, Paulsson A, Peiffer AM, Miller LD, Xu J, Hinson WH, Lesser GJ, Tatter SB, Debinski W, Chan MD. Genomic predictors of infield and marginal failure for glioblastoma treated with concurrent radiation therapy and temozolomide: a step towards personalized radiation fields? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S291-S292.

Lucas JT, Ayala-Peacock DN, Piazza M, Kuremsky JG, Page BR, Randolph D, Fitzgerald N, Holmes JA, Soike M, Tatter SB, Chan MD. A propensity score adjusted analysis of patients receiving up-front SRS versus WBRT: does the use of upfront WBRT really affect neurologic death? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S315-S316.

Ayala-Peacock DN, Attia A, Hepel J, Lucas JT, Onyeuku N, Stavas MJ, Taylor RB, Chung C, Fiveash J, Chan MD. A multi-institutional predictive nomogram for distant brain failure in patients treated with upfront stereotactic radiosurgery without whole brain radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S126.

Attia A, Page BR, Lesser GJ, Chan M. Treatment of radiation-induced cognitive decline. Curr Treat Options Oncol. 2014;15(4):539-550.

Okada H, Butterfield L, Hamilton R, Ahn B, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively M, Chan M, Salazar A, Shaw E, Potter D, Lieberman F. Induction of robust type-1 CD8(+) T-cell responses in WHO grade II low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC [abstract]. Neuro Oncol. 2014;16(Suppl 5):v114.

Strowd R, Russell G, Harmon M, Carter A, Chan M, Tatter S, Laxton A, High K, Lesser G. A pilot study of high-dose influenza vaccine immunogenicity in patients with primary central nervous system malignancy [abstract]. Neuro Oncol. 2014;16(Suppl 5):v207.

Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME [deceased], Shaw EG, Chan MD. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013;80(8):747-753.

Vincent A, Lesser G, Brown D, Vern-Gross T, Metheny-Barlow L, Lawrence J, Chan M. Prolonged regression of metastatic leptomeningeal breast cancer that has failed conventional therapy: a case report and review of the literature. J Breast Cancer. 2013;16(1):122-126.

Chan MD, Shaw EG, Tatter SB. Radiosurgical management of trigeminal neuralgia. Neurosurg Clin N Am. 2013;24(4):613-621.

Kuhn E, Taksler GB, Dayton O, Loganathan A, Bourland J, Ellis TL [deceased], Laxton AW, Shaw EG, Chan MD, Tatter SB. Adverse toxicity after stereotactic radiosurgery for treatment of meningiomas [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S259.

Kuremsky JG, Lester SC, Lucas JT, Randolph DM, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on whether metastases are symptomatic or not: an argument for routine brain screening [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S178-S179.

Lucas JT, Colmer HG, White GL, Isom SP, Ellis TL [deceased], Urbanic JJ, Tatter SB, Chan MD. A competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage following whole brain radiation therapy failure (WBRT): who actually dies of their brain metastases? [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S52.

Randolph D, Peiffer AM, Klepin H, Ayala-Peacock DN, Lester SC, Laxton AW, Tatter SB, Shaw EG, Chan MD. Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S609.

Kuhn EN, Taksler GB, Dayton O, Loganathan AG, Vern-Gross TZ, Bourland JD, Laxton AW, Chan MD, Tatter SB. Patterns of recurrence after stereotactic radiosurgery for treatment of meningiomas. Neurosurg Focus. 2013;35(6):E14.

Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL [deceased], McMullen KP, Shaw EG, Chan MD. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery. 2013;73(4):641-647.

Okada H, Butterfield L, Hamilton R, Drappatz J, Engh J, Amankulor N, Lively M, Chan M, Salazar A, Potter D, Shaw E, Lieberman F. Robust induction of type-1 CD8(+) T-cell responses INWHOgrade II low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC [abstract]. Neuro Oncol. 2013;15(Suppl 3):71.

Peiffer AM, Burke A, Leyer CM, Shing E, Kearns WT, Hinson WH, Case D, Rapp SR, Shaw EG, Chan MD. Normal tissue complication probability (Ntcp) model of radiation-induced mood disruption [abstract]. Neuro Oncol. 2013;15(Suppl 3):230.

Shaw EG, Case D, Bryant D, Grisell D, Lesser G, Monitto DC, Naughton MJ, Rapp SR, Sovano SR, Shah S, Chan MD. Phase II double-blind placebo-controlled study of armodafinil for brain radiation induced fatigue [abstract]. J Clin Oncol. 2013;31(15 Suppl):9505.

Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG. A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012;82(2):743-748.

Chan MD, McMullen KP. Multidisciplinary management of intracranial ependymoma. Curr Probl Cancer. 2012;36(1):6-19.

Ellis TL, Neal MT, Chan MD. The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol. 2012;2012():952345.

Geer CP, Simonds J, Anvery A, Chen MY, Burdette JH, Zapadka ME, Ellis TL, Tatter SB, Lesser GJ, Chan MD, McMullen KP, Johnson AJ. Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study. AJNR Am J Neuroradiol. 2012;33(3):556-562.

Marshall K, Chan MD, McCoy TP, Aubuchon AC, Bourland JD, McMullen KP, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Ellis TL. Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery. Neurosurgery. 2012;70(3):566-573.

Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, Bourland JD, Munley MT, deGuzman AF, Shaw EG, Urbanic JJ, McMullen KP. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):e53-e59.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Radiation Oncology

Michael D. Chan, M.D.

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology
Comprehensive Cancer Center
Brain Tumor Center of Excellence

Doctor Rating

4.8 out of 5

Michael D. Chan, M.D.197 Ratings
16 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.8
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

7/20/2015

Dr. Chan and his gamma knife program should be actively supported by this medical center, coordinating services between his department, medical oncology and diagnostic radiology. This is the type of program that should be highlighted for the excellence it exhibits.

7/2/2015

Restored my faith in doctors.

6/25/2015

My entire experience was way above expectations.

6/10/2015

good

5/4/2015

Very impressed with Dr. Chan.

3/23/2015

Dr. Chan is an excellent physician: well trained, well informed about my case, and very caring.

3/20/2015

Wake Forest Baptist is a #1 hospital.

2/25/2015

Dr Chan gave verbal and hand written instructions on tapering medication. Reviewed with to make certain she understood

2/21/2015

Excellent

2/19/2015

Very good.

1/20/2015

pleasant, personable, open, engaging which makes it easy to share relevant info and get meaningful answers to questions

1/13/2015

Dr Chan is an excellent physician. I feel comfortable in his care.

12/29/2014

Follow up visit.

12/26/2014

Everyone knew their job and performed with the highest degree of professionalism.

10/1/2014

Doctor Chan is a excellent care provider. I could not ask for better

9/3/2014

great communication excellent compassionate physician

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.